利索-全球专利检索

  1. 登录
  2. 注册
发明公开
CN103930100A R(+)-N-甲基-炔丙基-氨基茚满 无效 - 驳回

R(+)-N-甲基-炔丙基-氨基茚满
摘要：
本发明提供R(+)-N-甲基-炔丙基氨基茚满或其药学上可接受的盐，和包含R(+)-N-炔丙基-1(R)-氨基茚满或其药学上可接受的盐和R(+)-N-甲基-炔丙基-氨基茚满化合物或其盐的组合物。本发明还公开了根据R(+)-N-甲基-炔丙基-氨基茚满或其盐的含量，验证雷沙吉兰批次用于药物制剂的方法，和验证雷沙吉兰制剂用于分发的方法。
摘要（英）：

The subject invention provides R(+)-N-methyl-propargylaminoindan or a pharmaceutically acceptable salt thereof and a composition containing R(+)-N-propargyl-1(R)-aminoindan or a pharmaceutically acceptable salt thereof and a compound of R(+)-N-methyl-propargyl-aminoindan or a salt thereof. Also disclosed are methods of validating a batch of rasagiline for use in a pharmaceutical formulation and a method of validating a rasagiline formulation for distribution, based on the content of R(+)-N-methyl -propargyl-aminoindan or a salt thereof.

0/0